Article
Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
Pathogens and global health - 1 Jun 2017
Mishra Sweta, Bharti Praveen K, Shukla Man M, Ali Nazia A, Kashyotia Sher S, Kumar Avdhesh, Dhariwal Akshay C, Singh Neeru
Abstract excerpt
The spread of P. falciparum resistant strain has led to a significant resurgence of malaria morbidity and mortality. The current cornerstone in malaria treatment in India is Artemisinin based Combination (Artesunate + Sulphadoxine-Pyrimethamine) Therapy (ACT) for treatment of uncomplicated P. falciparum malaria since 2010. In the present study we assessed the therapeutic efficacy of ACT and molecular monitoring...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.